| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same |
| 06/03/2009 | CN101445504A Dioxane-2-alkyl carbamates derivatives |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/02/2009 | US7541378 tert-butyl 3-amino-1H-thieno[2,3-c]pyrazole-5-carboxylate; N-benzyl-3-[(4-fluorobenzoyl)amino]-1H-thieno[2,3-c]pyrazole-5-carboxamide; treats a disease caused associated with an altered (disregulated) protein kinase activity e.g cancer, cell proliferative disorders, Alzheimer's disease, viral infections |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541339 Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541027 polyclonal antibodies, monoclonal antibodies, F(ab')2, Fab and single chain Fv; tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor |
| 06/02/2009 | CA2434277C Substituted alkylamine derivatives and methods of use |
| 06/02/2009 | CA2386890C Artificial tear replacement solution |
| 06/02/2009 | CA2344290C Quinazoline derivatives |
| 06/02/2009 | CA2326137C Method for stabilizing pharmaceutical compositions by special use of an antioxidant |
| 06/02/2009 | CA2304425C Novel pyrazolone compound and ophthalmic plastic lens using the same |
| 05/28/2009 | WO2009067438A1 Use of trpv1 receptor antagonists for treating dry eye and ocular pain |
| 05/28/2009 | WO2009067407A2 Compositions of matrix metalloproteinase activating endopeptidases for reducing intraocular pressure, and methods of use thereof |
| 05/28/2009 | WO2009067081A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/28/2009 | WO2009066775A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same |
| 05/28/2009 | WO2009043527A3 Therapeutic use of human growth hormone 1-43 |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137686 Treatment of Ophthalmic Diseases |
| 05/28/2009 | US20090137629 Sigma receptor binding agent containing indanone derivative |
| 05/28/2009 | US20090137604 corticotropin releasing factor receptor antagonists such as 8-(N-butyl-N-(2-butynyl)amino)-2-methyl-3-(2-chloro-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine, used for the treatment of nervous system, psychological, eating, sleep, and gastrointestinal disorders |
| 05/28/2009 | US20090137581 Heterocyclic compounds and their uses |
| 05/28/2009 | US20090137539 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136598 Compositions for the Treatment and Prevention of Eyelid Swelling |
| 05/28/2009 | US20090136466 Methods for making skin cell derived stem cells |
| 05/28/2009 | DE102007055046A1 Infusionslösung Solution for infusion |
| 05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 05/28/2009 | CA2704214A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/27/2009 | EP2061749A1 Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate |
| 05/27/2009 | EP2061444A2 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 05/27/2009 | EP1548032B1 Kdr peptides and vaccines comprising the same |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | CN101443359A Antibodies to EGFL7 and methods for their use |
| 05/27/2009 | CN101443079A Antibacterial extracellular polysaccharide solvating system |
| 05/27/2009 | CN101443042A Use of IL-1 antibodies for treating ophthalmic disorders |
| 05/27/2009 | CN101443004A Formulations and methods for vascular permeability-related diseases or conditions |
| 05/27/2009 | CN101439152A Chinese medicinal composition for treating pearl eye as well as preparation method thereof and quality control method |
| 05/27/2009 | CN101439139A Chinese herbal medicine composition for treating tinnitus and deafness |
| 05/27/2009 | CN101439131A Chinese medicinal composition for treating phonosensitive nerve deafness and use thereof |
| 05/27/2009 | CN101439091A Agent for nursing eye skin by eliminating and alleviating cell fatigue of eye skin |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100490915C Otolaryngological delivery device |
| 05/27/2009 | CN100490809C Tablet comprising cetirizine and pseudoephedrine |
| 05/27/2009 | CN100490804C Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2464223C Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2342211C Antibiotic compositions for treatment of the eye, ear and nose |
| 05/26/2009 | CA2295512C Prostaglandin product |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/22/2009 | WO2009065022A2 Low density lipoprotein receptor-mediated sirna delivery |
| 05/22/2009 | WO2009064983A1 Methods and compositions for treating dry eye |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063885A1 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan) |
| 05/22/2009 | WO2009063821A1 Heteroaryloxy quinazoline derivative |
| 05/22/2009 | WO2009063215A2 Use of crth2 antagonist compounds |
| 05/22/2009 | WO2009063202A2 Use of crth2 antagonist compounds |
| 05/22/2009 | WO2009062402A1 Quinazolinone derivatives, the preparation methods and uses thereof |
| 05/22/2009 | WO2009044294A3 Means and methods for the treatment of cataract and presbyopia |
| 05/22/2009 | CA2705370A1 Heteroaryloxy quinazoline derivatives |
| 05/22/2009 | CA2703814A1 Methods and compositions for treating dry eye |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131404 Combinations |
| 05/21/2009 | US20090131358 LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY |
| 05/21/2009 | US20090131347 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a th1 phenotype |
| 05/21/2009 | US20090131307 Pharmaceutical compositions comprising cyclosporins |
| 05/21/2009 | US20090131303 Methods and compositions for treating dry eye |
| 05/21/2009 | US20090130192 Class iii slrp agonists for the reduction of blood vessel formation |
| 05/21/2009 | US20090130176 Intraocular lens with drug delivery system attached thereto |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060265A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/20/2009 | EP2060264A1 Agent for treating eye diseases |
| 05/20/2009 | EP2059597A2 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions |
| 05/20/2009 | EP2059507A2 Ep2 agonists |
| 05/20/2009 | EP2059250A2 Compounds for the treatment of angiogenesis |
| 05/20/2009 | EP1565467B1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 05/20/2009 | DE102007054653A1 Use of thiourea derivative to degrade advanced glycation end-products, Maillard-products and Amadori products and to prepare medicament to inhibit skin diseases during diabetes and to treat e.g. cataract, arthritis and Alzheimer's disease |
| 05/20/2009 | CN101437543A Combination comprising a VEGF inhibitor and a serine protease for treating neovascular diseases |
| 05/20/2009 | CN101434648A Peptide for inhibiting angiogenesis, and use thereof in angiogenesis medicament preparation |
| 05/20/2009 | CN101433721A Nimesulide-hydroxypropyl-beta-cyclodextrin inclusion compound eye drops and preparation method thereof |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433711A Chinese medicinal composition for treating deafness |
| 05/20/2009 | CN101433679A Pharmaceutical composition for treating pearl eye |
| 05/20/2009 | CN101433678A Chinese medicinal prescription for treating Meniere's disease |